View in EDS HTML Full Text PDF Full Text

Teriparatide use is associated with increased odds of 2-year implant failure and revision in osteopenic patients undergoing cervical fusion.

Saved in:
Bibliographic Details
Title: Teriparatide use is associated with increased odds of 2-year implant failure and revision in osteopenic patients undergoing cervical fusion.
Authors: Ng, Mitchell K.1 (AUTHOR) mitchng77@gmail.com, Mastrokostas, Paul G.1,2 (AUTHOR), Mastrokostas, Leonidas E.1,2 (AUTHOR), Tabbaa, Ameer1 (AUTHOR), Johnson, Matthew1 (AUTHOR), Monsef, Jad Bou1,2 (AUTHOR), Razi, Afshin E.1 (AUTHOR)
Source: Journal of Craniovertebral Junction & Spine. Apr-Jun2025, Vol. 16 Issue 2, p157-161. 5p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09748237
DOI:10.4103/jcvjs.jcvjs_30_25